Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
about
Dual Allosteric Inhibitors Jointly Modulate Protein Structure and Dynamics in the Hepatitis C Virus Polymerase.Allosteric inhibitors have distinct effects, but also common modes of action, in the HCV polymerase.Classification of HCV NS5B polymerase inhibitors using support vector machine.Synthesis of tetrahydropyridazines by a metal-carbene-directed enantioselective vinylogous N-H insertion/Lewis acid-catalyzed diastereoselective Mannich addition.Highly enantioselective dearomatizing formal [3+3] cycloaddition reactions of N-acyliminopyridinium ylides with electrophilic enol carbene intermediates.Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges.Structure-activity relationships in the development of allosteric hepatitis C virus RNA-dependent RNA polymerase inhibitors: ten years of research.A study of the allosteric inhibition of HCV RNA-dependent RNA polymerase and implementing virtual screening for the selection of promising dual-site inhibitors with low resistance potential.Computational predictions suggest that structural similarity in viral polymerases may lead to comparable allosteric binding sites.Molecular simulations to delineate functional conformational transitions in the HCV polymerase.Quantitative structure and bioactivity relationship study on HCV NS5B polymerase inhibitors.Combined 3D-QSAR, molecular docking, molecular dynamics simulation, and binding free energy calculation studies on the 5-hydroxy-2H-pyridazin-3-one derivatives as HCV NS5B polymerase inhibitors.Synthesis of 2-fluoro-2-pyrrolines via tandem reaction of α-trifluoromethyl-α,β-unsaturated carbonyl compounds with N-tosylated 2-aminomalonates.A novel reaction of gem-difluorocyclopropyl ketones with nitriles leading to 2-fluoropyrroles.
P2860
Q30375558-F68DF7A8-ADFD-40C0-AC02-D13BD3E7698CQ35333600-2194B538-D09E-4719-A08A-BCBF7E05180BQ35933857-31653988-97A5-4B4A-B299-2083A5C2AC15Q36452754-52910165-23A6-481E-9E1D-344719384DA4Q37382395-FA29605A-5D55-440B-AF61-7D771677090BQ37855859-44295646-DC56-4976-A01A-765139E53B42Q38034733-C7FB656F-BAB9-4D5D-851A-8F6C5392953CQ38796994-3E141284-8415-46B4-8A2C-02C18F8A7781Q40102776-FC6BCEE7-5936-41A3-9A76-3403F8BB3EE3Q40470134-29D8B06E-68DC-48FF-97BA-3E691A40B263Q42252644-F94D99D3-2746-4EDB-BBE7-100D9A589D0CQ42276983-B40B202E-DB97-42C3-92BF-5AA8BF2EA00EQ50428271-9211753F-C4FB-4926-A80F-0E453CD11D4FQ53090421-43208AA6-A632-4D66-9924-DC8207B37DCA
P2860
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
@ast
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
@en
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
@nl
type
label
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
@ast
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
@en
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
@nl
prefLabel
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
@ast
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
@en
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
@nl
P2093
P1476
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
@en
P2093
Amit M Shah
Charles R Kissinger
Chinh V Tran
Daniel A Norris
Darian M Bartkowski
Douglas E Murphy
Frank Ruebsam
Jingjing Zhao
Laurie A Lebrun
Leo Kirkovsky
P304
P356
10.1016/J.BMCL.2008.04.066
P407
P577
2008-06-15T00:00:00Z